Water Quality in SHALLOWATER, TX (79363)
EPA violation data for public water systems serving ZIP code 79363.
1,778
Total Violations
332
Health-Based
1,446
Monitoring / Reporting
1,490
Resolved
What does this mean?
1,490 of 1,778 violations have been resolved. 332 are health-based violations, meaning contaminant levels exceeded federal safety limits. The remaining 1,446 are monitoring or reporting violations (missed testing deadlines or late paperwork — not necessarily a water quality issue). Not all violations mean your water is unsafe. The EPA requires reporting even for minor administrative issues.
Violations Detail (1778 total)
| Contaminant | Category | MCL Limit | Measured | Date | Status | Health Effects |
|---|---|---|---|---|---|---|
| Public Notice | Monitoring | N/A | N/A | Sep 12, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 12, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 12, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 12, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 12, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 12, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 12, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 12, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 12, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 7, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 7, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 23, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 23, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 23, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 23, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 23, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 23, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 23, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 23, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 23, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 9, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 9, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 9, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 9, 2025 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Selenium | Health-Based | N/A | 0.06 | Jun 30, 2025 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Health-Based | N/A | 4.7 | Jun 30, 2025 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.4 | Jun 30, 2025 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 19, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 19, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 19, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 19, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 19, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2025 | Active | N/A |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Eye and nose irritation; stomach discomfort |
| Selenium | Health-Based | N/A | 0.07 | Mar 31, 2025 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Health-Based | N/A | 0.07 | Mar 31, 2025 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Fluoride | Health-Based | N/A | 4.7 | Mar 31, 2025 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Health-Based | N/A | 4.7 | Mar 31, 2025 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Chlorine | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Eye and nose irritation; stomach discomfort |
| Fluoride | Health-Based | N/A | 4.4 | Mar 31, 2025 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.4 | Mar 31, 2025 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Mar 20, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 9, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 9, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 23, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 23, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 23, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 23, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 23, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 23, 2025 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Active | N/A |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Health-Based | N/A | 4.8 | Dec 31, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.8 | Dec 31, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Active | N/A |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Active | N/A |
| Fluoride | Health-Based | N/A | 4.4 | Dec 31, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.4 | Dec 31, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Dec 6, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 6, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 6, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 6, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 6, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 6, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 6, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 6, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 6, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 18, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 18, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 22, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 22, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 22, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 22, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 22, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| Fluoride | Health-Based | N/A | 4.8 | Sep 30, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Selenium | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Fluoride | Health-Based | N/A | 4.8 | Sep 30, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Selenium | Health-Based | N/A | 0.07 | Sep 30, 2024 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Health-Based | N/A | 0.07 | Sep 30, 2024 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Fluoride | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Health-Based | N/A | 4.4 | Sep 30, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.4 | Sep 30, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Aug 28, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 28, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 28, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 28, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 28, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 28, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 28, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 28, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 20, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 20, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 17, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 17, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 23, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 23, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 23, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 23, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 23, 2024 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Active | N/A |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Selenium | Health-Based | N/A | 0.07 | Jun 30, 2024 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Health-Based | N/A | 0.07 | Jun 30, 2024 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Fluoride | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Selenium | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Fluoride | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Selenium | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Active | N/A |
| Combined Uranium | Health-Based | N/A | 58 | Jun 30, 2024 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 58 | Jun 30, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Active | N/A |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Health-Based | N/A | 4.8 | Jun 30, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Fluoride | Health-Based | N/A | 4.8 | Jun 30, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Tritium | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Fluoride | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.5 | Jun 30, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.5 | Jun 30, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Combined Uranium | Health-Based | N/A | 124 | Jun 30, 2024 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 124 | Jun 30, 2024 | Resolved | N/A |
| Nitrate | Health-Based | N/A | 11 | Jun 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Active | N/A |
| Tritium | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Nitrate | Health-Based | N/A | 11 | Jun 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Fluoride | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Active | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Active | N/A |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| 38-STRONTIUM-90 | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| 38-STRONTIUM-90 | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| 53-IODINE-131 | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| 53-IODINE-131 | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 30, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 30, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 30, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 30, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 30, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 30, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 30, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 30, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 1, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 1, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 1, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 1, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 1, 2024 | Active | N/A |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Health-Based | N/A | 4.8 | Mar 31, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.8 | Mar 31, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Selenium | Health-Based | N/A | 0.08 | Mar 31, 2024 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Health-Based | N/A | 0.08 | Mar 31, 2024 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Selenium | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 45 | Mar 31, 2024 | Resolved | N/A |
| Nitrate | Health-Based | N/A | 11 | Mar 31, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Health-Based | N/A | 11 | Mar 31, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Combined Uranium | Health-Based | N/A | 45 | Mar 31, 2024 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Fluoride | Health-Based | N/A | 4.5 | Mar 31, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Health-Based | N/A | 20 | Mar 31, 2024 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Health-Based | N/A | 20 | Mar 31, 2024 | Resolved | N/A |
| Fluoride | Health-Based | N/A | 4.5 | Mar 31, 2024 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| 38-STRONTIUM-90 | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| 38-STRONTIUM-90 | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Tritium | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Tritium | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| 53-IODINE-131 | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| 53-IODINE-131 | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Nitrate | Health-Based | N/A | 11 | Mar 31, 2024 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Public Notice | Monitoring | N/A | N/A | Mar 28, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 28, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 27, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 27, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 16, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 16, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 1, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 1, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 1, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 1, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 1, 2024 | Active | N/A |
| Selenium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Active | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 60 | Dec 31, 2023 | Resolved | N/A |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Selenium | Health-Based | N/A | 0.08 | Dec 31, 2023 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Health-Based | N/A | 0.08 | Dec 31, 2023 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 60 | Dec 31, 2023 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Fluoride | Health-Based | N/A | 4.8 | Dec 31, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Increased risk of cancer |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| BHC-GAMMA | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Chlordane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Atrazine | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Cardiovascular system or reproductive problems |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Fluoride | Health-Based | N/A | 4.8 | Dec 31, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Selenium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Tritium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 130 | Dec 31, 2023 | Resolved | N/A |
| Tritium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 130 | Dec 31, 2023 | Resolved | N/A |
| 38-STRONTIUM-90 | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 38-STRONTIUM-90 | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Increased risk of cancer |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Active | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 53-IODINE-131 | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Liver problems; increased risk of cancer |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Health-Based | N/A | 4.6 | Dec 31, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.6 | Dec 31, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| 53-IODINE-131 | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 30, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 30, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 30, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 30, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 30, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 30, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 30, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 30, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 15, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 15, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 15, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 15, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 15, 2023 | Active | N/A |
| Selenium | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Arsenic | Health-Based | N/A | 0.011 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Selenium | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Fluoride | Health-Based | N/A | 4.8 | Sep 30, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.8 | Sep 30, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Fluoride | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Selenium | Health-Based | N/A | 0.08 | Sep 30, 2023 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Health-Based | N/A | 0.08 | Sep 30, 2023 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Fluoride | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Health-Based | N/A | 60 | Sep 30, 2023 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 60 | Sep 30, 2023 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Tritium | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 130 | Sep 30, 2023 | Resolved | N/A |
| 53-IODINE-131 | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Fluoride | Health-Based | N/A | 4.8 | Sep 30, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| 38-STRONTIUM-90 | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| 38-STRONTIUM-90 | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| 53-IODINE-131 | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Fluoride | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Tritium | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Fluoride | Health-Based | N/A | 4.8 | Sep 30, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Combined Uranium | Health-Based | N/A | 130 | Sep 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 19, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 19, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 19, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 19, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 19, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 19, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 19, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 19, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 17, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 17, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 17, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 17, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 17, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 17, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 17, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 17, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 17, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 17, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 17, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 17, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 17, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 17, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 12, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 12, 2023 | Active | N/A |
| Selenium | Health-Based | N/A | 0.07 | Jun 30, 2023 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Active | N/A |
| Selenium | Health-Based | N/A | 0.07 | Jun 30, 2023 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Fluoride | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Selenium | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Active | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Fluoride | Health-Based | N/A | 4.8 | Jun 30, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Fluoride | Health-Based | N/A | 4.8 | Jun 30, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Combined Uranium | Health-Based | N/A | 61 | Jun 30, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 61 | Jun 30, 2023 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Active | N/A |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Health-Based | N/A | 4.9 | Jun 30, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.9 | Jun 30, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Active | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| 38-STRONTIUM-90 | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| 38-STRONTIUM-90 | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| 53-IODINE-131 | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| 53-IODINE-131 | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Tritium | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Tritium | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Active | N/A |
| Combined Uranium | Health-Based | N/A | 135 | Jun 30, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 135 | Jun 30, 2023 | Resolved | N/A |
| Fluoride | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Jun 8, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 8, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 8, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 8, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 8, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 8, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 8, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 8, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 16, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 16, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 16, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 16, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 20, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 20, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 20, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 20, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 20, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 20, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 20, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 20, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 20, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 20, 2023 | Active | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Selenium | Health-Based | N/A | 0.07 | Mar 31, 2023 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Health-Based | N/A | 0.07 | Mar 31, 2023 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Health-Based | N/A | 0.07 | Mar 31, 2023 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Health-Based | N/A | 62 | Mar 31, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 62 | Mar 31, 2023 | Resolved | N/A |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Selenium | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Fluoride | Health-Based | N/A | 4.8 | Mar 31, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.8 | Mar 31, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.8 | Mar 31, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| 53-IODINE-131 | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| 53-IODINE-131 | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 31, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 31, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 31, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 31, 2023 | Active | N/A |
| 38-STRONTIUM-90 | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| 38-STRONTIUM-90 | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 140 | Mar 31, 2023 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Tritium | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 140 | Mar 31, 2023 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Health-Based | N/A | 4.9 | Mar 31, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.9 | Mar 31, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.9 | Mar 31, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Tritium | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 15, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 15, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 15, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 15, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2023 | Active | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Atrazine | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Active | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Active | N/A |
| Combined Uranium | Health-Based | N/A | 60 | Dec 31, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 60 | Dec 31, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 60 | Dec 31, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Selenium | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Selenium | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Selenium | Health-Based | N/A | 0.07 | Dec 31, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Health-Based | N/A | 0.07 | Dec 31, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Health-Based | N/A | 0.07 | Dec 31, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.011 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Health-Based | N/A | 4.8 | Dec 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.8 | Dec 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.8 | Dec 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Increased risk of cancer |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Methoxychlor | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Active | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Toxaphene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Active | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Increased risk of cancer |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.014 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.014 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Health-Based | N/A | 5 | Dec 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Fluoride | Health-Based | N/A | 5 | Dec 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Combined Uranium | Health-Based | N/A | 137 | Dec 31, 2022 | Resolved | N/A |
| Fluoride | Health-Based | N/A | 5 | Dec 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Liver problems; increased risk of cancer |
| Combined Uranium | Health-Based | N/A | 137 | Dec 31, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 137 | Dec 31, 2022 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 2, 2022 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 2, 2022 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 18, 2022 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 18, 2022 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 18, 2022 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 18, 2022 | Active | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Fluoride | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Combined Uranium | Health-Based | N/A | 60 | Sep 30, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 60 | Sep 30, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 60 | Sep 30, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Selenium | Health-Based | N/A | 0.07 | Sep 30, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Health-Based | N/A | 0.07 | Sep 30, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Health-Based | N/A | 0.07 | Sep 30, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Fluoride | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Health-Based | N/A | 4.9 | Sep 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Fluoride | Health-Based | N/A | 4.9 | Sep 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.9 | Sep 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Selenium | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Selenium | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Fluoride | Health-Based | N/A | 4.8 | Sep 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.8 | Sep 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.8 | Sep 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Health-Based | N/A | 0.016 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Health-Based | N/A | 140 | Sep 30, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 140 | Sep 30, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 140 | Sep 30, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Fluoride | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Sep 12, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 12, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 12, 2022 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 12, 2022 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 3, 2022 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 3, 2022 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 20, 2022 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 20, 2022 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 20, 2022 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 20, 2022 | Active | N/A |
| Selenium | Health-Based | N/A | 0.07 | Jun 30, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Selenium | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Selenium | Health-Based | N/A | 0.07 | Jun 30, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Active | N/A |
| Fluoride | Health-Based | N/A | 4.9 | Jun 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.9 | Jun 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.9 | Jun 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Health-Based | N/A | 55 | Jun 30, 2022 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Health-Based | N/A | 55 | Jun 30, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 55 | Jun 30, 2022 | Resolved | N/A |
| Selenium | Health-Based | N/A | 0.07 | Jun 30, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Health-Based | N/A | 0.015 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.015 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Fluoride | Health-Based | N/A | 4.8 | Jun 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Combined Uranium | Health-Based | N/A | 136 | Jun 30, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 136 | Jun 30, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 136 | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Active | N/A |
| Fluoride | Health-Based | N/A | 4.8 | Jun 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.8 | Jun 30, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 3, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 3, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 13, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 13, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 13, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 13, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 13, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 13, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 13, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 13, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 13, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 54 | Mar 31, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 54 | Mar 31, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 54 | Mar 31, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 54 | Mar 31, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Health-Based | N/A | 4.8 | Mar 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.8 | Mar 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.8 | Mar 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.8 | Mar 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Selenium | Health-Based | N/A | 0.08 | Mar 31, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Health-Based | N/A | 0.08 | Mar 31, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Health-Based | N/A | 0.08 | Mar 31, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Selenium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Selenium | Health-Based | N/A | 0.08 | Mar 31, 2022 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.016 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Health-Based | N/A | 131 | Mar 31, 2022 | Resolved | N/A |
| Fluoride | Health-Based | N/A | 4.7 | Mar 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Fluoride | Health-Based | N/A | 4.7 | Mar 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.7 | Mar 31, 2022 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 131 | Mar 31, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Health-Based | N/A | 20 | Mar 31, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Combined Uranium | Health-Based | N/A | 131 | Mar 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Health-Based | N/A | 20 | Mar 31, 2022 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Health-Based | N/A | 20 | Mar 31, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 20, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 16, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 16, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 16, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 16, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 29, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 55 | Dec 31, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 55 | Dec 31, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 55 | Dec 31, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 55 | Dec 31, 2021 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Selenium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Arsenic | Health-Based | N/A | 0.013 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Selenium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Arsenic | Health-Based | N/A | 0.013 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Methoxychlor | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Fluoride | Health-Based | N/A | 4.7 | Dec 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.7 | Dec 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Atrazine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Cardiovascular system or reproductive problems |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Methoxychlor | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Selenium | Health-Based | N/A | 0.08 | Dec 31, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Health-Based | N/A | 0.08 | Dec 31, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Fluoride | Health-Based | N/A | 4.7 | Dec 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.7 | Dec 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Increased risk of cancer |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Active | N/A |
| Selenium | Health-Based | N/A | 0.08 | Dec 31, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Health-Based | N/A | 0.08 | Dec 31, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Active | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Active | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Trichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.015 | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Fluoride | Health-Based | N/A | 4.5 | Dec 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Fluoride | Health-Based | N/A | 4.5 | Dec 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.5 | Dec 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Increased risk of cancer |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Increased risk of cancer |
| Vinyl chloride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Tetrachloroethylene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Active | N/A |
| Combined Uranium | Health-Based | N/A | 129 | Dec 31, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 129 | Dec 31, 2021 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 129 | Dec 31, 2021 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Xylenes, Total | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 27, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 27, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 27, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 27, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 27, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 27, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 27, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 27, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 27, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 27, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 27, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 27, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 27, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 27, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 18, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 18, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 20, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 20, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 20, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 20, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 20, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 1, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 1, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Combined Uranium | Health-Based | N/A | 57 | Sep 30, 2021 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Fluoride | Health-Based | N/A | 4.6 | Sep 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.6 | Sep 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.6 | Sep 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Selenium | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| TTHM | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Selenium | Health-Based | N/A | 0.09 | Sep 30, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| TTHM | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Selenium | Health-Based | N/A | 0.09 | Sep 30, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Health-Based | N/A | 0.09 | Sep 30, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Health-Based | N/A | 0.09 | Sep 30, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Selenium | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Combined Uranium | Health-Based | N/A | 57 | Sep 30, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 57 | Sep 30, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 57 | Sep 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Fluoride | Health-Based | N/A | 4.6 | Sep 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Selenium | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Health-Based | N/A | 4.5 | Sep 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Health-Based | N/A | 4.5 | Sep 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.5 | Sep 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.5 | Sep 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Combined Uranium | Health-Based | N/A | 121 | Sep 30, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Combined Uranium | Health-Based | N/A | 121 | Sep 30, 2021 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.014 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Health-Based | N/A | 121 | Sep 30, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 121 | Sep 30, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 121 | Sep 30, 2021 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.014 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Fluoride | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Fluoride | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| TTHM | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| TTHM | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 29, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 22, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 22, 2021 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Jul 13, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jul 13, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jul 13, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jul 13, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jul 13, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jul 13, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jul 13, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jul 13, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jul 13, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Public Notice | Monitoring | N/A | N/A | Jul 7, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 7, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 7, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 7, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 7, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 7, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 7, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 7, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 7, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 7, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 7, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 57 | Jun 30, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Selenium | Health-Based | N/A | 0.09 | Jun 30, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Health-Based | N/A | 0.09 | Jun 30, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Selenium | Health-Based | N/A | 0.09 | Jun 30, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Health-Based | N/A | 0.09 | Jun 30, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Health-Based | N/A | 57 | Jun 30, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 57 | Jun 30, 2021 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Health-Based | N/A | 57 | Jun 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Active | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Fluoride | Health-Based | N/A | 4.5 | Jun 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.5 | Jun 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Fluoride | Health-Based | N/A | 4.5 | Jun 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Fluoride | Health-Based | N/A | 4.5 | Jun 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Active | N/A |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Fluoride | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Health-Based | N/A | 0.014 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Health-Based | N/A | 119 | Jun 30, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 119 | Jun 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Active | N/A |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Arsenic | Health-Based | N/A | 0.014 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Active | N/A |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Active | N/A |
| Fluoride | Health-Based | N/A | 4.3 | Jun 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Health-Based | N/A | 0.014 | Jun 30, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Fluoride | Health-Based | N/A | 4.3 | Jun 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.3 | Jun 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.3 | Jun 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 119 | Jun 30, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 119 | Jun 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 3, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 3, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 21, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 21, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 21, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 21, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 21, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 21, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 21, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 21, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 21, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 21, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 21, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 21, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 21, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 21, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 21, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 21, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 21, 2021 | Resolved | N/A |
| Selenium | Health-Based | N/A | 0.08 | Mar 31, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Health-Based | N/A | 0.08 | Mar 31, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Fluoride | Health-Based | N/A | 4.6 | Mar 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.6 | Mar 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.6 | Mar 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.6 | Mar 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 56 | Mar 31, 2021 | Resolved | N/A |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Combined Uranium | Health-Based | N/A | 56 | Mar 31, 2021 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Health-Based | N/A | 56 | Mar 31, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 56 | Mar 31, 2021 | Resolved | N/A |
| Selenium | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Health-Based | N/A | 0.08 | Mar 31, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Health-Based | N/A | 0.08 | Mar 31, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Fluoride | Health-Based | N/A | 4.2 | Mar 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Health-Based | N/A | 0.014 | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Gross Alpha, Excl. Radon and U | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Fluoride | Health-Based | N/A | 4.2 | Mar 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Fluoride | Health-Based | N/A | 4.2 | Mar 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Health-Based | N/A | 4.2 | Mar 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Combined Uranium | Health-Based | N/A | 123 | Mar 31, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 123 | Mar 31, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Combined Uranium | Health-Based | N/A | 123 | Mar 31, 2021 | Resolved | N/A |
| Combined Uranium | Health-Based | N/A | 123 | Mar 31, 2021 | Resolved | N/A |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Fluoride | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Bone disease (pain and tenderness of the bones); children may get mottled teeth |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Mar 10, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 10, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 17, 2021 | Resolved | N/A |
Lead & Copper Levels
Violation Timeline
2025(73)
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Lead and Copper Rule
52
Lead and Copper Rule
52
Selenium
02
Arsenic
02
Fluoride
02
Fluoride
02
Arsenic
02
Lead and Copper Rule
52
Lead and Copper Rule
52
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Chlorine
27
Selenium
02
Selenium
02
Fluoride
02
Arsenic
02
Arsenic
02
Fluoride
02
Chlorine
27
Fluoride
02
Fluoride
02
Arsenic
02
Arsenic
02
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
2024(219)
Lead and Copper Rule
52
Arsenic
02
Arsenic
02
Fluoride
02
Fluoride
02
Lead and Copper Rule
52
Lead and Copper Rule
52
Arsenic
02
Lead and Copper Rule
52
Fluoride
02
Fluoride
02
Arsenic
02
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
LEAD AND COPPER RULE REVISIONS
4G
LEAD AND COPPER RULE REVISIONS
2E
LEAD AND COPPER RULE REVISIONS
2E
LEAD AND COPPER RULE REVISIONS
4G
LEAD AND COPPER RULE REVISIONS
2E
LEAD AND COPPER RULE REVISIONS
2E
LEAD AND COPPER RULE REVISIONS
4G
LEAD AND COPPER RULE REVISIONS
4G
Fluoride
02
Arsenic
03
Arsenic
03
Fluoride
03
Fluoride
03
Selenium
03
Selenium
03
Fluoride
02
Selenium
02
Selenium
02
Arsenic
02
Arsenic
02
Arsenic
03
Nitrate
03
Nitrate
03
Fluoride
03
Arsenic
03
Fluoride
02
Fluoride
02
Fluoride
03
Arsenic
02
Arsenic
02
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Consumer Confidence Rule
71
Arsenic
02
Arsenic
02
Selenium
02
Selenium
02
Fluoride
03
Selenium
03
Fluoride
03
Selenium
03
Lead and Copper Rule
52
Combined Uranium
02
Combined Uranium
02
Lead and Copper Rule
52
Arsenic
03
Gross Alpha, Excl. Radon and U
03
Arsenic
03
Fluoride
02
Gross Alpha, Excl. Radon and U
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Fluoride
02
Combined Uranium
03
Combined Uranium
03
Gross Alpha, Excl. Radon and U
03
Tritium
03
Fluoride
03
Fluoride
02
Fluoride
02
Combined Uranium
02
Combined Uranium
02
Nitrate
01
Consumer Confidence Rule
71
Tritium
03
Nitrate
01
Nitrate
03
Nitrate
03
Fluoride
03
Combined Uranium
03
Lead and Copper Rule
52
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Lead and Copper Rule
52
Arsenic
03
Arsenic
03
Arsenic
02
Arsenic
02
Combined Uranium
03
38-STRONTIUM-90
03
38-STRONTIUM-90
03
53-IODINE-131
03
53-IODINE-131
03
Gross Alpha, Excl. Radon and U
03
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Arsenic
03
Arsenic
03
Fluoride
02
Fluoride
02
Selenium
02
Selenium
02
Arsenic
02
Arsenic
02
Selenium
03
Selenium
03
Combined Uranium
03
Gross Alpha, Excl. Radon and U
03
Combined Uranium
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Fluoride
03
Fluoride
03
Gross Alpha, Excl. Radon and U
03
Combined Uranium
02
Nitrate
01
Nitrate
01
Arsenic
03
Fluoride
03
Fluoride
03
Combined Uranium
02
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Fluoride
02
Combined Uranium
03
Gross Alpha, Excl. Radon and U
02
Gross Alpha, Excl. Radon and U
02
Fluoride
02
Arsenic
02
38-STRONTIUM-90
03
38-STRONTIUM-90
03
Arsenic
02
Combined Uranium
03
Combined Radium (-226 and -228)
03
Tritium
03
Tritium
03
Arsenic
03
Combined Radium (-226 and -228)
03
53-IODINE-131
03
Nitrate
03
Nitrate
03
53-IODINE-131
03
Nitrate
01
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
2023(404)
Selenium
03
Lead and Copper Rule
52
Lead and Copper Rule
52
Di(2-ethylhexyl) adipate
03
Simazine
03
Simazine
03
Gross Alpha, Excl. Radon and U
03
trans-1,2-Dichloroethylene
03
Methoxychlor
03
Heptachlor
03
Heptachlor
03
CHLOROBENZENE
03
LASSO
03
LASSO
03
CHLOROBENZENE
03
Hexachlorocyclopentadiene
03
Hexachlorocyclopentadiene
03
Benzene
03
Benzene
03
1,2-Dichloropropane
03
Toxaphene
03
p-Dichlorobenzene
03
Combined Uranium
02
Fluoride
03
Fluoride
03
trans-1,2-Dichloroethylene
03
Di(2-ethylhexyl) adipate
03
Nitrate
03
Nitrate
03
Combined Uranium
03
Combined Uranium
03
p-Dichlorobenzene
03
Toxaphene
03
Di(2-ethylhexyl) phthalate
03
Di(2-ethylhexyl) phthalate
03
HEXACHLOROBENZENE
03
Tetrachloroethylene
03
HEXACHLOROBENZENE
03
Benzo(a)pyrene
03
Ethylbenzene
03
Ethylbenzene
03
Selenium
02
Selenium
02
Gross Alpha, Excl. Radon and U
03
Styrene
03
Benzo(a)pyrene
03
Pentachlorophenol
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Uranium
02
1,2-Dichloroethane
03
1,2-Dichloroethane
03
Fluoride
02
Pentachlorophenol
03
Endrin
03
Vinyl chloride
03
Vinyl chloride
03
Arsenic
02
Arsenic
02
Arsenic
03
Arsenic
03
Toluene
03
Chlordane
03
Endrin
03
Methoxychlor
03
Styrene
03
Toluene
03
1,1,2-Trichloroethane
03
Carbon tetrachloride
03
Carbon tetrachloride
03
BHC-GAMMA
03
Trichloroethylene
03
Trichloroethylene
03
Chlordane
03
Heptachlor epoxide
03
Heptachlor epoxide
03
cis-1,2-Dichloroethylene
03
cis-1,2-Dichloroethylene
03
TTHM
27
Atrazine
03
Atrazine
03
TTHM
27
1,2,4-Trichlorobenzene
03
BHC-GAMMA
03
1,1,2-Trichloroethane
03
Fluoride
02
1,2,4-Trichlorobenzene
03
Xylenes, Total
03
Xylenes, Total
03
DICHLOROMETHANE
03
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
DICHLOROMETHANE
03
Tetrachloroethylene
03
Selenium
03
o-Dichlorobenzene
03
o-Dichlorobenzene
03
1,1-Dichloroethylene
03
1,1-Dichloroethylene
03
1,1,1-Trichloroethane
03
1,1,1-Trichloroethane
03
1,2-Dichloropropane
03
Arsenic
03
Arsenic
03
Nitrate
03
Nitrate
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
o-Dichlorobenzene
03
o-Dichlorobenzene
03
Tritium
03
Combined Uranium
02
Tritium
03
Combined Uranium
02
38-STRONTIUM-90
03
38-STRONTIUM-90
03
Fluoride
03
1,1-Dichloroethylene
03
Fluoride
03
Ethylbenzene
03
Ethylbenzene
03
Vinyl chloride
03
Vinyl chloride
03
Carbon tetrachloride
03
Carbon tetrachloride
03
Trichloroethylene
03
1,2-Dichloroethane
03
Trichloroethylene
03
Benzene
03
Gross Alpha, Excl. Radon and U
03
Benzene
03
Gross Alpha, Excl. Radon and U
03
Combined Uranium
03
Combined Uranium
03
1,2,4-Trichlorobenzene
03
1,1,2-Trichloroethane
03
1,1,1-Trichloroethane
03
1,1,1-Trichloroethane
03
1,1,2-Trichloroethane
03
1,2,4-Trichlorobenzene
03
Lead and Copper Rule
52
Lead and Copper Rule
52
cis-1,2-Dichloroethylene
03
TTHM
27
trans-1,2-Dichloroethylene
03
trans-1,2-Dichloroethylene
03
Xylenes, Total
03
1,2-Dichloropropane
03
p-Dichlorobenzene
03
p-Dichlorobenzene
03
53-IODINE-131
03
1,1-Dichloroethylene
03
CHLOROBENZENE
03
CHLOROBENZENE
03
Tetrachloroethylene
03
Toluene
03
Toluene
03
Styrene
03
Styrene
03
TTHM
27
1,2-Dichloropropane
03
Tetrachloroethylene
03
Xylenes, Total
03
cis-1,2-Dichloroethylene
03
DICHLOROMETHANE
03
Arsenic
02
1,2-Dichloroethane
03
Arsenic
02
Fluoride
02
Fluoride
02
53-IODINE-131
03
DICHLOROMETHANE
03
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Selenium
03
Arsenic
02
Selenium
03
Fluoride
02
Fluoride
02
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Fluoride
03
Selenium
02
Selenium
02
Fluoride
03
Arsenic
03
Combined Uranium
02
Combined Uranium
03
Combined Uranium
02
Combined Uranium
03
Arsenic
03
Arsenic
02
Arsenic
03
Tritium
03
Combined Uranium
02
53-IODINE-131
03
Fluoride
02
38-STRONTIUM-90
03
38-STRONTIUM-90
03
Arsenic
02
Arsenic
02
Nitrate
03
Nitrate
03
Gross Alpha, Excl. Radon and U
03
53-IODINE-131
03
Combined Uranium
03
Fluoride
03
Fluoride
03
Arsenic
03
Combined Uranium
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Gross Alpha, Excl. Radon and U
03
Tritium
03
Fluoride
02
Combined Uranium
02
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Selenium
02
Consumer Confidence Rule
71
Selenium
02
Gross Alpha, Excl. Radon and U
03
Fluoride
03
Fluoride
03
Selenium
03
Selenium
03
Arsenic
03
Arsenic
03
Arsenic
02
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Combined Radium (-226 and -228)
03
Combined Uranium
03
Combined Uranium
03
Fluoride
02
Combined Radium (-226 and -228)
03
Fluoride
02
Combined Uranium
02
Combined Uranium
02
Gross Alpha, Excl. Radon and U
03
Consumer Confidence Rule
71
Arsenic
02
Fluoride
02
Fluoride
03
Fluoride
02
Nitrate
03
Nitrate
03
Arsenic
03
Combined Uranium
03
Combined Uranium
03
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
38-STRONTIUM-90
03
38-STRONTIUM-90
03
Arsenic
02
Arsenic
02
53-IODINE-131
03
53-IODINE-131
03
Tritium
03
Tritium
03
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Combined Uranium
02
Combined Uranium
02
Fluoride
03
Arsenic
03
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Selenium
02
Selenium
02
Selenium
02
Arsenic
02
Arsenic
02
Arsenic
02
Combined Uranium
02
Combined Uranium
02
Fluoride
03
Fluoride
03
Fluoride
03
Selenium
03
Selenium
03
Selenium
03
Combined Uranium
03
Combined Uranium
03
Fluoride
02
Fluoride
02
Fluoride
02
Arsenic
03
Arsenic
03
Arsenic
03
53-IODINE-131
03
53-IODINE-131
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
38-STRONTIUM-90
03
38-STRONTIUM-90
03
Combined Uranium
02
Arsenic
03
Arsenic
03
Arsenic
03
Combined Uranium
03
Combined Uranium
03
Tritium
03
Combined Uranium
02
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Arsenic
02
Arsenic
02
Arsenic
02
Fluoride
02
Fluoride
02
Fluoride
02
Fluoride
03
Fluoride
03
Fluoride
03
Nitrate
03
Nitrate
03
Nitrate
03
Tritium
03
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
2022(482)
1,2,4-Trichlorobenzene
03
1,1,2-Trichloroethane
03
Toxaphene
03
LASSO
03
LASSO
03
cis-1,2-Dichloroethylene
03
cis-1,2-Dichloroethylene
03
Hexachlorocyclopentadiene
03
Hexachlorocyclopentadiene
03
Atrazine
03
Atrazine
03
Lead and Copper Rule
52
Di(2-ethylhexyl) adipate
03
Di(2-ethylhexyl) adipate
03
Lead and Copper Rule
52
Combined Uranium
02
Combined Uranium
02
HEXACHLOROBENZENE
03
Ethylbenzene
03
Ethylbenzene
03
Combined Uranium
02
Heptachlor
03
Heptachlor
03
Heptachlor epoxide
03
Heptachlor epoxide
03
Benzo(a)pyrene
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
1,2,4-Trichlorobenzene
03
Di(2-ethylhexyl) phthalate
03
Benzo(a)pyrene
03
Pentachlorophenol
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Toluene
03
Toluene
03
Chlordane
03
Chlordane
03
Xylenes, Total
03
Xylenes, Total
03
DICHLOROMETHANE
03
DICHLOROMETHANE
03
o-Dichlorobenzene
03
o-Dichlorobenzene
03
p-Dichlorobenzene
03
Pentachlorophenol
03
Selenium
03
Di(2-ethylhexyl) phthalate
03
Selenium
03
Selenium
03
HEXACHLOROBENZENE
03
1,1,2-Trichloroethane
03
Gross Alpha, Excl. Radon and U
03
Simazine
03
p-Dichlorobenzene
03
1,1-Dichloroethylene
03
1,1-Dichloroethylene
03
trans-1,2-Dichloroethylene
03
trans-1,2-Dichloroethylene
03
1,2-Dichloroethane
03
Simazine
03
Endrin
03
Endrin
03
Selenium
02
Selenium
02
Selenium
02
Fluoride
03
Fluoride
03
Fluoride
03
Arsenic
03
Arsenic
03
Arsenic
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Arsenic
02
Arsenic
02
Arsenic
02
Fluoride
02
Fluoride
02
Fluoride
02
1,2-Dichloroethane
03
1,1,1-Trichloroethane
03
1,1,1-Trichloroethane
03
1,2-Dichloropropane
03
1,2-Dichloropropane
03
CHLOROBENZENE
03
CHLOROBENZENE
03
BHC-GAMMA
03
BHC-GAMMA
03
Methoxychlor
03
Styrene
03
Styrene
03
Vinyl chloride
03
Vinyl chloride
03
Carbon tetrachloride
03
Carbon tetrachloride
03
Trichloroethylene
03
Trichloroethylene
03
Tetrachloroethylene
03
Tetrachloroethylene
03
Benzene
03
Benzene
03
Methoxychlor
03
Lead and Copper Rule
52
Nitrate
03
Nitrate
03
Toxaphene
03
Benzene
03
Ethylbenzene
03
cis-1,2-Dichloroethylene
03
Ethylbenzene
03
cis-1,2-Dichloroethylene
03
Xylenes, Total
03
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Xylenes, Total
03
o-Dichlorobenzene
03
Benzene
03
o-Dichlorobenzene
03
1,2-Dichloroethane
03
Vinyl chloride
03
Vinyl chloride
03
Carbon tetrachloride
03
Carbon tetrachloride
03
Tetrachloroethylene
03
Tetrachloroethylene
03
p-Dichlorobenzene
03
p-Dichlorobenzene
03
1,1-Dichloroethylene
03
Arsenic
02
Arsenic
02
1,1-Dichloroethylene
03
trans-1,2-Dichloroethylene
03
trans-1,2-Dichloroethylene
03
1,2-Dichloroethane
03
Arsenic
02
Fluoride
02
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
DICHLOROMETHANE
03
DICHLOROMETHANE
03
Fluoride
02
Combined Uranium
02
Fluoride
02
Trichloroethylene
03
Trichloroethylene
03
Combined Uranium
02
Combined Uranium
02
1,1,1-Trichloroethane
03
1,1,1-Trichloroethane
03
1,2-Dichloropropane
03
1,2-Dichloropropane
03
1,1,2-Trichloroethane
03
1,1,2-Trichloroethane
03
1,2,4-Trichlorobenzene
03
1,2,4-Trichlorobenzene
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Combined Uranium
03
CHLOROBENZENE
03
CHLOROBENZENE
03
Nitrate
03
Nitrate
03
Nitrate
03
Fluoride
03
Fluoride
03
Fluoride
03
Toluene
03
Toluene
03
Combined Uranium
03
Arsenic
03
Arsenic
03
Arsenic
03
Styrene
03
Styrene
03
Combined Uranium
03
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Combined Uranium
03
Combined Uranium
03
Fluoride
03
Combined Uranium
02
Combined Uranium
02
Combined Uranium
02
Combined Uranium
03
Selenium
02
Selenium
02
Selenium
02
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Fluoride
03
Fluoride
03
Arsenic
02
Arsenic
02
Arsenic
02
Fluoride
02
Combined Radium (-226 and -228)
03
Fluoride
02
Fluoride
02
Selenium
03
Selenium
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Selenium
03
Arsenic
03
Arsenic
03
Arsenic
03
Arsenic
02
Arsenic
03
Nitrate
03
Fluoride
02
Fluoride
02
Fluoride
02
Arsenic
02
Arsenic
02
Nitrate
03
Nitrate
03
Arsenic
03
Combined Uranium
02
Combined Uranium
02
Combined Uranium
02
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Combined Radium (-226 and -228)
03
Fluoride
03
Fluoride
03
Fluoride
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Arsenic
03
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Selenium
02
Combined Uranium
03
Combined Uranium
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Selenium
03
Selenium
03
Arsenic
02
Arsenic
02
Arsenic
02
Selenium
02
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Fluoride
02
Fluoride
02
Fluoride
02
Fluoride
03
Fluoride
03
Fluoride
03
Arsenic
03
Combined Uranium
02
Arsenic
03
Arsenic
03
Combined Uranium
02
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Combined Uranium
02
Selenium
02
Selenium
03
Combined Uranium
03
Gross Alpha, Excl. Radon and U
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Nitrate
03
Nitrate
03
Nitrate
03
Arsenic
03
Arsenic
03
Arsenic
03
Fluoride
03
Fluoride
03
Fluoride
03
Arsenic
02
Arsenic
02
Combined Radium (-226 and -228)
03
Arsenic
02
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Fluoride
02
Combined Uranium
02
Combined Uranium
02
Combined Uranium
02
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Fluoride
02
Fluoride
02
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Lead and Copper Rule
52
Lead and Copper Rule
52
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Combined Uranium
02
Combined Uranium
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Uranium
03
Combined Uranium
02
Combined Uranium
02
Combined Uranium
02
Combined Uranium
03
Arsenic
02
Arsenic
02
Arsenic
02
Arsenic
02
Fluoride
02
Fluoride
02
Fluoride
02
Fluoride
02
Selenium
02
Selenium
02
Selenium
02
Arsenic
03
Arsenic
03
Fluoride
03
Fluoride
03
Arsenic
03
Arsenic
03
Fluoride
03
Fluoride
03
Selenium
03
Selenium
03
Selenium
03
Selenium
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Selenium
02
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Arsenic
02
Arsenic
02
Arsenic
02
Fluoride
03
Fluoride
03
Fluoride
03
Arsenic
03
Arsenic
03
Arsenic
03
Combined Uranium
02
Fluoride
02
Combined Radium (-226 and -228)
03
Fluoride
02
Fluoride
02
Nitrate
03
Combined Uranium
03
Combined Uranium
02
Combined Uranium
03
Combined Uranium
03
Gross Alpha, Excl. Radon and U
02
Nitrate
03
Combined Uranium
02
Gross Alpha, Excl. Radon and U
02
Gross Alpha, Excl. Radon and U
02
Nitrate
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
2021(600)
BHC-GAMMA
03
BHC-GAMMA
03
BHC-GAMMA
03
Benzo(a)pyrene
03
Ethylbenzene
03
Ethylbenzene
03
cis-1,2-Dichloroethylene
03
cis-1,2-Dichloroethylene
03
cis-1,2-Dichloroethylene
03
Xylenes, Total
03
Xylenes, Total
03
Xylenes, Total
03
DICHLOROMETHANE
03
DICHLOROMETHANE
03
DICHLOROMETHANE
03
1,1-Dichloroethylene
03
1,1-Dichloroethylene
03
1,1-Dichloroethylene
03
trans-1,2-Dichloroethylene
03
trans-1,2-Dichloroethylene
03
trans-1,2-Dichloroethylene
03
1,1,1-Trichloroethane
03
1,1,1-Trichloroethane
03
1,1,1-Trichloroethane
03
1,2-Dichloropropane
03
1,2-Dichloropropane
03
1,2-Dichloropropane
03
1,1,2-Trichloroethane
03
1,1,2-Trichloroethane
03
1,1,2-Trichloroethane
03
CHLOROBENZENE
03
CHLOROBENZENE
03
CHLOROBENZENE
03
Toluene
03
Toluene
03
Toluene
03
Endrin
03
Endrin
03
Endrin
03
Simazine
03
Simazine
03
Simazine
03
LASSO
03
LASSO
03
LASSO
03
Heptachlor
03
Heptachlor
03
Heptachlor
03
Heptachlor epoxide
03
Heptachlor epoxide
03
Heptachlor epoxide
03
HEXACHLOROBENZENE
03
HEXACHLOROBENZENE
03
HEXACHLOROBENZENE
03
Pentachlorophenol
03
Pentachlorophenol
03
Pentachlorophenol
03
Chlordane
03
Chlordane
03
Chlordane
03
p-Dichlorobenzene
03
Ethylbenzene
03
o-Dichlorobenzene
03
Arsenic
03
Arsenic
03
Fluoride
03
Fluoride
03
Fluoride
03
Benzo(a)pyrene
03
Fluoride
03
Benzo(a)pyrene
03
Combined Uranium
02
Combined Uranium
02
Combined Uranium
02
Combined Uranium
02
o-Dichlorobenzene
03
Selenium
03
Selenium
03
Selenium
03
Arsenic
02
Arsenic
02
Selenium
03
Arsenic
02
Arsenic
02
Hexachlorocyclopentadiene
03
Hexachlorocyclopentadiene
03
Hexachlorocyclopentadiene
03
o-Dichlorobenzene
03
Di(2-ethylhexyl) adipate
03
Vinyl chloride
03
Tetrachloroethylene
03
Tetrachloroethylene
03
Tetrachloroethylene
03
Benzene
03
Benzene
03
Benzene
03
Methoxychlor
03
Methoxychlor
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Styrene
03
Fluoride
02
Fluoride
02
Styrene
03
Carbon tetrachloride
03
Carbon tetrachloride
03
Atrazine
03
Atrazine
03
Atrazine
03
Nitrate
03
Nitrate
03
Nitrate
03
Methoxychlor
03
p-Dichlorobenzene
03
p-Dichlorobenzene
03
Selenium
02
Selenium
02
Carbon tetrachloride
03
1,2,4-Trichlorobenzene
03
1,2,4-Trichlorobenzene
03
1,2,4-Trichlorobenzene
03
Fluoride
02
Fluoride
02
Styrene
03
Vinyl chloride
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Toxaphene
03
Toxaphene
03
Toxaphene
03
Trichloroethylene
03
Trichloroethylene
03
Trichloroethylene
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
1,2-Dichloroethane
03
1,2-Dichloroethane
03
1,2-Dichloroethane
03
Combined Uranium
03
Di(2-ethylhexyl) phthalate
03
Di(2-ethylhexyl) phthalate
03
Vinyl chloride
03
Lead and Copper Rule
52
Selenium
02
Selenium
02
Arsenic
03
Arsenic
03
Lead and Copper Rule
52
Di(2-ethylhexyl) phthalate
03
Lead and Copper Rule
52
Di(2-ethylhexyl) adipate
03
Di(2-ethylhexyl) adipate
03
o-Dichlorobenzene
03
Xylenes, Total
03
p-Dichlorobenzene
03
p-Dichlorobenzene
03
1,2,4-Trichlorobenzene
03
1,2,4-Trichlorobenzene
03
1,2,4-Trichlorobenzene
03
Gross Alpha, Excl. Radon and U
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Toluene
03
Toluene
03
Toluene
03
Trichloroethylene
03
Trichloroethylene
03
Trichloroethylene
03
Arsenic
02
Arsenic
02
Arsenic
02
cis-1,2-Dichloroethylene
03
cis-1,2-Dichloroethylene
03
cis-1,2-Dichloroethylene
03
Fluoride
02
p-Dichlorobenzene
03
1,1-Dichloroethylene
03
Fluoride
02
Fluoride
02
Arsenic
03
Arsenic
03
Arsenic
03
1,1-Dichloroethylene
03
1,1-Dichloroethylene
03
1,2-Dichloroethane
03
1,2-Dichloroethane
03
1,2-Dichloroethane
03
1,1,1-Trichloroethane
03
1,1,1-Trichloroethane
03
Fluoride
03
Fluoride
03
Fluoride
03
1,1,1-Trichloroethane
03
1,2-Dichloropropane
03
Benzene
03
Combined Radium (-226 and -228)
03
1,2-Dichloropropane
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
o-Dichlorobenzene
03
o-Dichlorobenzene
03
1,2-Dichloropropane
03
1,1,2-Trichloroethane
03
1,1,2-Trichloroethane
03
1,1,2-Trichloroethane
03
Benzene
03
CHLOROBENZENE
03
CHLOROBENZENE
03
Vinyl chloride
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
CHLOROBENZENE
03
trans-1,2-Dichloroethylene
03
trans-1,2-Dichloroethylene
03
trans-1,2-Dichloroethylene
03
Vinyl chloride
03
Vinyl chloride
03
Carbon tetrachloride
03
Carbon tetrachloride
03
Carbon tetrachloride
03
Tetrachloroethylene
03
Tetrachloroethylene
03
Tetrachloroethylene
03
Ethylbenzene
03
Ethylbenzene
03
Ethylbenzene
03
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Combined Uranium
02
Combined Uranium
02
Styrene
03
Styrene
03
DICHLOROMETHANE
03
Nitrate
03
Nitrate
03
Nitrate
03
Styrene
03
DICHLOROMETHANE
03
DICHLOROMETHANE
03
Xylenes, Total
03
Combined Uranium
02
Benzene
03
Xylenes, Total
03
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Total Haloacetic Acids (HAA5)
27
Arsenic
02
Arsenic
03
Arsenic
03
Chlorine
27
Combined Uranium
02
Chlorine
27
Chlorine
27
Chlorine
27
Fluoride
02
Fluoride
02
Fluoride
02
Selenium
03
Chlorine
27
Arsenic
03
TTHM
27
Selenium
02
TTHM
27
TTHM
27
Combined Uranium
03
Selenium
02
Selenium
02
Selenium
02
Arsenic
02
Combined Uranium
03
Combined Uranium
03
Arsenic
02
Fluoride
03
Fluoride
03
Arsenic
02
Fluoride
03
Selenium
03
Combined Uranium
02
Combined Uranium
02
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Combined Radium (-226 and -228)
03
Combined Uranium
02
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Fluoride
02
Selenium
03
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
Combined Uranium
03
Combined Uranium
03
Arsenic
03
Fluoride
02
Arsenic
03
Fluoride
02
Fluoride
02
Fluoride
02
Combined Uranium
02
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Chlorine
27
Chlorine
27
Chlorine
27
Combined Uranium
02
Arsenic
02
Combined Uranium
02
Combined Uranium
02
Combined Uranium
02
Arsenic
02
Arsenic
02
Arsenic
02
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Fluoride
03
Fluoride
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Fluoride
03
Fluoride
03
TTHM
27
Arsenic
03
Arsenic
03
TTHM
27
TTHM
27
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
Total Haloacetic Acids (HAA5)
27
Combined Uranium
03
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
E. COLI
34
E. COLI
34
E. COLI
34
E. COLI
34
E. COLI
34
E. COLI
34
E. COLI
34
E. COLI
34
E. COLI
34
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Combined Uranium
02
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Selenium
02
Selenium
02
Combined Uranium
03
Consumer Confidence Rule
71
Selenium
02
Selenium
02
Arsenic
02
Combined Uranium
02
Combined Uranium
02
Chlorine
27
Arsenic
02
Arsenic
02
Arsenic
02
Combined Uranium
02
Lead and Copper Rule
52
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Chlorine
27
Chlorine
27
Fluoride
02
Fluoride
02
Chlorine
27
Fluoride
02
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Fluoride
02
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Chlorine
27
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Nitrate
03
Nitrate
03
Nitrate
03
Fluoride
03
Fluoride
03
Arsenic
02
Fluoride
03
Arsenic
03
Arsenic
03
Combined Uranium
02
Combined Uranium
02
Consumer Confidence Rule
71
Arsenic
03
Arsenic
03
Arsenic
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Chlorine
27
Chlorine
27
Arsenic
02
Arsenic
02
Nitrate
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Lead and Copper Rule
52
Chlorine
27
Chlorine
27
Lead and Copper Rule
52
Lead and Copper Rule
52
Fluoride
02
Arsenic
02
Nitrate
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Fluoride
02
Fluoride
02
Fluoride
02
Fluoride
03
Fluoride
03
Lead and Copper Rule
52
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Combined Uranium
02
Combined Uranium
02
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Selenium
02
Selenium
02
Fluoride
02
Fluoride
02
Fluoride
02
Fluoride
02
Arsenic
03
Arsenic
03
Arsenic
03
Arsenic
03
Gross Alpha, Excl. Radon and U
03
Arsenic
02
Arsenic
02
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Uranium
02
Fluoride
03
Fluoride
03
Fluoride
03
Fluoride
03
Combined Uranium
02
Arsenic
02
Combined Uranium
02
Combined Uranium
02
Selenium
03
Selenium
03
Selenium
02
Selenium
02
Selenium
03
Selenium
03
Gross Alpha, Excl. Radon and U
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Arsenic
02
Arsenic
02
Arsenic
02
Fluoride
02
Arsenic
02
Arsenic
02
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Gross Alpha, Excl. Radon and U
03
Combined Uranium
03
Combined Uranium
03
Fluoride
02
Combined Uranium
03
Combined Uranium
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Fluoride
02
Fluoride
02
Arsenic
03
Arsenic
03
Arsenic
03
Combined Uranium
02
Combined Uranium
02
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Combined Uranium
02
Combined Uranium
02
Fluoride
03
Fluoride
03
Fluoride
03
Fluoride
03
Fluoride
03
Arsenic
03
Arsenic
03
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
How Does This Compare?
SHALLOWATER (79363) has 1,778 recorded violations, including 332 health-based. 288 remain unresolved. Consider testing your tap water independently for added peace of mind.
Recommended Water Filters
Based on the contaminants detected in your area, these filter types may help improve your water quality.
Reverse Osmosis System
Highly effective at removing heavy metals, dissolved solids, and a wide range of contaminants. Recommended for homes with lead or arsenic concerns.
Targets:Lead, Copper, Arsenic, Mercury, Cadmium
Look for:NSF/ANSI 58 certified
Activated Carbon Filter
Excellent for removing chlorine, chloramine, and disinfection byproducts like THMs and HAAs. Available as pitcher filters, countertop, or under-sink units.
Targets:THMs, HAAs, Chlorine, Chloramine, Taste & Odor
Look for:NSF/ANSI 42 & 53 certified
UV Water Purifier
Uses ultraviolet light to neutralize bacteria, viruses, and parasites without chemicals. Ideal for homes with microbial contamination concerns.
Targets:E. coli, Coliform, Giardia, Cryptosporidium
Look for:NSF/ANSI 55 (Class A) certified
Always look for filters certified by NSF International for the specific contaminants you want to remove.